Occuity specialises in the research, design and production of non-contacting optical instruments for use in healthcare diagnostics and monitoring.
Occuity’s meters work by shining light into the eye and analysing the return signal. This enables direct measurements of the eye for optometrists and ophthalmologists but also, and perhaps more importantly, other more general health conditions such as diabetes and Alzheimer’s Disease to be monitored.
Occuity's Intellectual Property includes 9 international patents covering the measurement technique and optical technology that forms the basis of the devices along with additional patents relating to the alignment and measurements within the eye.
Occuity's mission is to create a range of non-contact, handheld devices which by their nature will be useable in a non-clinical setting by healthcare professionals and also personal monitoring devices for diseases such as diabetes.
Non-contact diagnostics through the eye.
Building upon our patented technology, Occuity's disease screening products, will make it easier and cheaper to screen for diseases including diabetes and Alzheimer's in non-clinical settings such as high street pharmacies and care homes.
Better. Easier. Safer.
News & Blog
Unfortunately Coronavirus (COVID-19) is causing many issues for individuals, families and businesses. Our best wishes are with everyone as they deal with the evolving situation.
As circumstances unfold, we wanted to update you on our position. Prudent measures are being put in place to protect the company and our employees. Occuity already operates a flexible working policy for all of our staff that facilitates home working as and when required. Now, following Government guidance, we have implemented this across the business for all staff for the foreseeable future. Administrative tasks are easy to perform in a virtual environment and each engineer has been set up with the facilities they require so development can progress unimpeded.
The steps now being taken by Occuity, therefore, mean that the development of the business and its products can continue over the coming months with minimal disruption and, it is believed, with little impact on the long term prospects for the business.
Occuity will continue to monitor the situation closely and update this message should any revisions become necessary.